HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prevention mouthrinse safety to be re-reviewed by FDA plaque subcommittee.

This article was originally published in The Rose Sheet

Executive Summary

PREVENTION MOUTHRINSE SAFETY RE-REVIEW called for by FDA's Dental Plaque Subcommittee following a motion to table any recommendation regarding the safety and efficacy of the product at the group's meeting in Gaithersburg, Md. May 27. The subcommittee decided to re-review the safety of Prevention Mouthrinse after realizing it had not received results from a six-month clinical trial prior to its initial analysis, subcommittee member Max Listgarten, DDS, University of Pennsylvania, explained. Based on the study results available at the time, Listgarten concluded the data for the oral mouthwash were sufficient to substantiate safety designating the ingredient combination Category I (safe and/or effective) but insufficient to establish efficacy classifying it as a Category III (data insufficient to permit classification) combination.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005491

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel